GC
HRMY icon

Globeflex Capital’s Harmony Biosciences HRMY Stock Holding History

Globeflex Capital’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$117K Hold
3,203
– – 0.01% 360
2026
Q1 		$89.7K Hold
3,203
– – 0.01% 364
2025
Q4 		$120K Hold
3,203
– – 0.02% 362
2025
Q3 		$88.3K Hold
3,203
– – 0.01% 373
2025
Q2 		$101K Hold
3,203
– – 0.01% 378
2025
Q1 		$106K Hold
3,203
– – 0.01% 381
2024
Q4 		$110K Hold
3,203
– – 0.01% 377
2024
Q3 		$128K Buy
+3,203
New +$113K 0.01% 357

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Globeflex Capital's HRMY Position: Q2 2026 in Review

Globeflex Capital held its Harmony Biosciences (HRMY) position steady in Q2 2026 at 3,203 shares worth $117K. The position accounts for 0.01% of the portfolio, ranked #360.

Globeflex Capital first reported a position in HRMY in Q3 2024 and has held it in 8 quarters since. The position peaked at $128K in Q3 2024. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Globeflex Capital held 3,203 shares of Harmony Biosciences worth $117K as of Q2 2026.
  • Globeflex Capital left its Harmony Biosciences share count unchanged in Q2 2026.
  • Harmony Biosciences made up 0.01% of Globeflex Capital's portfolio in Q2 2026, its #360 holding.
  • Globeflex Capital first reported a position in Harmony Biosciences in Q3 2024 and has held it in 8 quarters since.
  • Globeflex Capital's Harmony Biosciences position peaked at $128K in Q3 2024.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Globeflex Capital's 13F filing for Q2 2026, filed 12 Aug 2026.